Abstract:Abstract Background: Long noncoding RNAs (lncRNAs) are promising cancer biomarkers and therapeutic targets . And lipid metabolism reprogramming is a trait of cancer metabolism. However, the relationship between lncRNAs and lipid metabolism and their prognostic value are still unclear in glioma. Hence, we screened for prognostic lncRNAs associated with lipid metabolism and explored their potential biological functions and effects on glioma. Methods: The glioma data were obtained from TCGA and CGGA databases. Correlation analysis was used to identify the lncRNAs associated with lipid metabolism . The Cox and LASSO regression analysis were adopted to find prognostic lncRNAs, and further established ceRNA network, clustering and risk score models. CNV and somatic mutation data were used to explore the correlation between risk score and genomic alterations. GSVA and GSEA was adopted to reveal the potential biological functions of prognostic lncRNAs. The abundance of 22 immune cells was inferred by CIBERSORT algorithm . The TIDE algorithm and GDSC database were used to predict the patient's response to immunotherapy and chemotherapy, respectively. Human glioma cell lines were used for further experimental validation. CCK-8 and colony forming assays were adopted to evaluate the cell viability. The cell proliferation was detected by EdU assay. Transwell assay was used to evaluate the ability of cell invasion and migration. Results: A total of twenty prognostic lncRNAs associated with lipid metabolism were found, and a prognostic lncRNA signature was established. A high risk-score suggested a poor prognosis , more malignant clinicopathological and genomic aberrations features. The risk score was also an independent prognos tic factor. The high-risk patients were more likely to benefit from anti-PD1 treatment. The biological function of signature lncRNAs was mainly to regulate the biosynthesis and transportation of lipid (especially the fatty acid). Among signature lncRNAs, LINC01614 was associated with prognosis, genomic aberrations characteristics, m6A methylation modification, immune infiltration status, and chemotherapy response of patients with glioma. In vitro experiments, silencing the expression of LINC01614 could inhibit the viability, migration , and proliferation of glioma cells. Conclusions: A prognostic lncRNA signature containing twenty lncRNAs associated with lipid metabolism was established in glioma. The signature lncRNAs play an important role in the development of glioma by regulating lipid biosynthesis and transportation. Our study also provides a new perspective for understanding the lipid metabolism and the biological role of lncRNAs in glioma.

Identification and validation of a five-lncRNA prognostic signature related to Glioma using bioinformatics analysis

Prognostic and Predictive Value of a Long Non-coding RNA Signature in Glioma: A lncRNA Expression Analysis

Development of a Prognostic Five-Gene Signature for Diffuse Lower-Grade Glioma Patients

Identification of a five-lncRNA signature for the diagnosis and prognosis of gastric cancer

Identification of a Five-Pseudogene Signature for Predicting Survival and Its Cerna Network in Glioma

Identification of lncRNA Signature Associated With Pan-Cancer Prognosis

Development of a Prognostic Five-Gene Signature with Radiotherapy Guidance Significance for Diffuse Lower-Grade Glioma Patients Based on Large-Scale Sequencing Data

Identification and Validation of a Three-Gene Signature As a Candidate Prognostic Biomarker for Lower Grade Glioma

A Prognostic lncRNA Signature Associated with Lipid Metabolism in Glioma

Identification of a RNA-Seq based prognostic signature with five lncRNAs for lung squamous cell carcinoma.

A five‐microRNA signature for individualized prognosis evaluation and radiotherapy guidance in patients with diffuse lower‐grade glioma

Identification of Novel Lncrna Markers in Glioblastoma Multiforme and Their Clinical Significance: A Study Based on Multiple Sequencing Data

Identification of a five-long non-coding RNA signature to improve the prognosis prediction for patients with hepatocellular carcinoma

Identification of a cellular senescence-related-lncRNA (SRlncRNA) signature to predict the overall survival of glioma patients and the tumor immune microenvironment

An Immune Gene-Related Five-lncRNA Signature for to Predict Glioma Prognosis

Identification and validation of a six-lncRNA prognostic signature with its ceRNA networks and candidate drugs in lower-grade gliomas

Five long non-coding RNAs establish a prognostic nomogram and construct a competing endogenous RNA network in the progression of non-small cell lung cancer

A TGF-β Signaling-Related Lncrna Signature for Prediction of Glioma Prognosis, Immune Microenvironment, and Immunotherapy Response

Identification and validation of a novel 9-gene signature of non-specific classification to predict prognosis in glioma patients

Identification of robust diagnostic and prognostic gene signatures in different grades of gliomas: a retrospective study

Prognostic Value of an Autophagy-Related Five-Gene Signature for Lower-Grade Glioma Patients